Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis

…, S D'angelo, G Cuomo, L Fenu, S Generini… - Seminars in arthritis and …, 2003 - Elsevier
Objective: To evaluate the coagulative/fibrinolytic cascade and the circulating markers of the
endothelial injury in systemic sclerosis (SSc). Method: Plasma was obtained from 29 …

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut …

S Generini, R Giacomelli, R Fedi, A Fulminis… - Annals of the …, 2004 - ard.bmj.com
… If you wish to reuse any or all of this article please use the link below which will take you to
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

…, A De Luca, G Farina, M Candela, S Generini… - The Journal of …, 2002 - jrheum.org
… The fluid was then centrifuged at 500 g for 15 min at room temperature, and the recovered
cells were washed and counted; cytocentrifuged smears were stained with Wright’s stain for …

Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in …

…, D Bagchi, S Generini, S Guiducci… - Free Radical …, 2002 - Taylor & Francis
… for repeated measures followed by a multiple comparison Scheffe’s test to determine
differences between groups. The paired Student’s t-test was used for within-group comparisons …

The nervous system in systemic sclerosis (scleroderma): clinical features and pathogenetic mechanisms

MM Cerinic, S Generini, A Pignone, R Casale - Rheumatic Disease Clinics …, 1996 - Elsevier
Systemic sclerosis (SSc) involves the microvascular system 54 and leads to fibroblast
activation and excessive production of collagen. The skin and the internal organs (lung, heart, …

Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment.

…, N Del Papa, F Falcini, S Generini… - Clinical and …, 1998 - europepmc.org
Objective To assess the frequency of antiendothelial cell autoantibodies (AECAs) in a group
of patients with systemic sclerosis (SSc) and possible associations with clinical and …

Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement

R Livi, L Teghini, A Pignone, S Generini… - Annals of the …, 2002 - ard.bmj.com
… where U s and P s are respectively the urinary and plasma concentrations of the substance
S and V is the urinary volume in ml/min. Creatinine and PAH clearances were used to …

[PDF][PDF] Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades

…, L Riente, A Candelieri, S Generini… - Clinical and …, 2012 - clinexprheumatol.org
… DER LINDEN S: Employment perspectives of patients with ankylosing spondylitis. Ann …
CALIN A, ELSWOOD J, RIGG S et al.: Ankylosing spondylitis – an analytical review of 1500 …

Health‐related quality of life in systemic sclerosis as measured by the short form 36: Relationship with clinical and biologic markers

…, A Scarpato, A Pignone, S Generini… - Arthritis Care & …, 2004 - Wiley Online Library
Objective To evaluate health‐related quality of life (HRQOL) in patients with systemic sclerosis
(SSc) using the Short Form 36 (SF‐36) and to correlate SF‐36 scores with clinical and …

Estrogens and neuropeptides in Raynaud's phenomenon

S Generini, JR Seibold… - Rheumatic Disease …, 2005 - rheumatic.theclinics.com
Raynaud’s phenomenon (RP)[1] is characterized by repeated daily attacks of ischemia followed
by reperfusion at the acral level (hands, feet, tongue, nose) and internal organs [2, 3]. It …